___

• 1- Thangaratinam S, Rogozińska E, Jolly K, Glinkowski S, Duda W, Borowiack E, Khan K. Interventions to reduce or prevent obesity in pregnant women: a systematic review. Health Technology Assessment. 2012; 16(31):1366-5278.
• 2- Davies GA. L, Maxwell C, McLeod L. Obesity in Pregnancy, SOGC Clinical Practice Guideline. JOGC. 2010; 209:165-73.
• 3- Tenenbaum,- Gavish K, Hod M. Fetal Diagnosis and Therapy: Impact of maternal obesity on fetal health Karger.2013; 34: 1-7.
• 4- Hajagos-Tóth J, Ducza E, Samavati R, Vari S.G, Gaspar R. Obesity in pregnancy: a novel concept on the roles of adipokines in uterine contractility. Croatian Medical Journal. 2017; 58(2), 96-104.
• 5- Lashen H, Fear K, Sturdee DW, Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Hum Reprod. 2004; 19: 1644-1646.
• 6- Abdollahi M, Cushman M, Rosendaal FR, Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb Haemost. 2003; 89: 493-498.
• 7- Yogev Y, Catalano PM. Pregnancy and Obesity. Obstet Gynecol Clin N Am. 2009;36: 285-300.
• 8- Davies GA, Maxwell C, McLeod L. SOGC Clinical Practice Guidelines: Obesity in pregnancy. Int J Gynaecol Obstet. 2010; 110:1673- Tenenbaum,- Gavish K, Hod M. Fetal Diagnosis and Therapy: Impact of maternal obesity on fetal health. Karger.2013; 34 :1-7.
• 9- Caughey AB, Stotland NE, Washington AE, Escobar GJ. Who is at risk for prolonged and postterm pregnancy? Am J Obstet Gynecol. 2009;200: 683-5.10- American College of Obstetricans and Gynecologists Committee on Obstetric Practice. 2013; 549.
• 11- James A. Committee on Practice Bulletins-Obstetrics. Tromboembolism in pregnancy. Obstet Gynecol. 2011;118:718.
• 12- IOM (Institute of Medicine) and NRC (National ResearchCouncil). Weight Gain During Pregnancy:Reexamining the Guidelines. The National Academies Pres. Washington, DC; 2009.
• 13- The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril. 2008; 89: 505-522.
• 14- Jain A. P, Gavard J. A, Rice J. J, Catanzaro R. B, Artal R, Hopkins S. A. The Impact of Interpregnancy Weight Change on Birthweight in Obese Women. Obstetrical & Gynecological Survey. 2013; 68(6): 409-411.
• 15- Glazer N. L, Hendrickson A. F, Schellenbaum G. D, Mueller B. A. Weight Change and the Risk of Gestational Diabetes in Obese Women. Epidemiology. 2004; 15(6): 733-737.
• 16- American Diabetes Association. 2. Classification and Diagnosis of Diabetes. Diabetes Care. 2017; 40 (Supplement 1):11-24.
• 17- Clinical practice guidelines for healthy eating for the preventıon and treatment of metabolic and endocrine diseases in adults:cosponsored by the Amerıcan Association of clinical endocrinologists/ the American College of Endocrınology. Endocrine Practice. 2013;19 (Suppl 3).
• 18- Harborne L, Sattar N, Norman J.E, Fleming, R. Metformin and weight loss in obese womenwith polycystic ovary syndrome: comparison of doses. J Clin Endocrinol Metab. 2005; 90: 4593-8.
• 19- Li Z, Magione M, Tu W, et al (RAND Health Division, Santa Monica, Calif; Greater Los Angeles VA Healthcare System; Dept of Veterans Affairs, Cincinnati, Ohio). Meta - analysis: pharmacologic treatment of obesity. Ann Intern Med. 2005; 142: 532-46.
• 20- Snow V, Barry P, Fitterman N, Qaseem A, Weiss K. Pharmacologic and Surgical Management of Obesity in Primary Care: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2005;142: 525-31.